Genotype-Proteotype Linkage in the Wiskott-Aldrich Syndrome1

Wiskott-Aldrich syndrome (WAS) is a platelet/immunodeficiency disease arising from mutations of WAS protein (WASP), a hemopoietic cytoskeletal protein. Clinical symptoms vary widely from mild (X-linked thrombocytopenia) to life threatening. In this study, we examined the molecular effects of individual mutations by quantifying WASP in peripheral lymphocytes of 44 patients and identifying the molecular variant (collectively called proteotype). Nonpredicted proteotypes were found for 14 genotypes. These include WASP-negative lymphocytes found for five missense genotypes and WASP-positive lymphocytes for two nonsense, five frameshift, and two splice site genotypes. Missense mutations in the Ena/VASP homology 1 (EVH1) domain lead to decreased/absent WASP but normal mRNA levels, indicating that proteolysis causes the protein deficit. Because several of the EVH1 missense mutations alter WIP binding sites, the findings suggest that abrogation of WIP binding induces proteolysis. Whereas platelets of most patients were previously shown to lack WASP, WASP-positive platelets were found for two atypical patients, both of whom have mutations outside the EVH1 domain. WASP variants with alternative splicing and intact C-terminal domains were characterized for eight nonsense and frameshift genotypes. One of these, a nonsense genotype in a mild patient, supports expression of WASP lacking half of the proline-rich region. With one notable exception, genotype and proteotype were linked, indicating that a genotype-proteotype registry could be assembled to aid in predicting disease course and planning therapy for newly diagnosed infants. Knowledge of the molecular effect of mutations would aid also in identifying disease-modifying genes.

[1]  G. Roberto Burgio,et al.  The Wiskott-Aldrich syndrome , 1995, European Journal of Pediatrics.

[2]  Silvia Giliani,et al.  Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. , 2004, Blood.

[3]  E. Remold-O’Donnell,et al.  Early deficit of lymphocytes in Wiskott–Aldrich syndrome: possible role of WASP in human lymphocyte maturation , 2004, Clinical and experimental immunology.

[4]  Kohsuke Imai,et al.  Clinical course of patients with WASP gene mutations. , 2004, Blood.

[5]  F. Candotti,et al.  High incidence of lymphomas in a subgroup of wiskott–aldrich syndrome patients , 2003, British journal of haematology.

[6]  Michael J. Byrne,et al.  Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. , 2002, Molecular cell.

[7]  W. Lim,et al.  Structure of the N-WASP EVH1 Domain-WIP Complex Insight into the Molecular Basis of Wiskott-Aldrich Syndrome , 2002, Cell.

[8]  Y. Sasahara,et al.  Wiskott-Aldrich syndrome in a female. , 2002, Blood.

[9]  Adrian J. Thrasher,et al.  Wasp in immune-system organization and function , 2002, Nature Reviews Immunology.

[10]  E. Remold-O’Donnell,et al.  A novel protocol to identify mutations in patients with wiskott-Aldrich syndrome. , 2002, Blood cells, molecules & diseases.

[11]  E. Remold-O’Donnell,et al.  An Alu-mediated deletion at Xp11.23 leading to Wiskott-Aldrich syndrome , 2002, Human Genetics.

[12]  L. Notarangelo,et al.  Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. , 2002, Blood.

[13]  J. Whisstock,et al.  The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.

[14]  J. V. Stone,et al.  Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. , 2001, Blood.

[15]  M. Vihinen,et al.  Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain , 2000, Journal of Molecular Medicine.

[16]  M. Kirschner,et al.  Mechanism of N-Wasp Activation by Cdc42 and Phosphatidylinositol 4,5-Bisphosphate , 2000, The Journal of cell biology.

[17]  F. Frischknecht,et al.  A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization , 2000, Nature Cell Biology.

[18]  Michael K. Rosen,et al.  Autoinhibition and activation mechanisms of the Wiskott–Aldrich syndrome protein , 2000, Nature.

[19]  A Shcherbina,et al.  WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction. , 1999, Journal of immunology.

[20]  A. Fischer,et al.  The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. , 1999, Blood.

[21]  W. Lim,et al.  Structure of the Enabled/VASP Homology 1 Domain–Peptide Complex A Key Component in the Spatial Control of Actin Assembly , 1999, Cell.

[22]  D. Nelson,et al.  Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. , 1999, Journal of immunology.

[23]  T. Hagemann,et al.  The identification and characterization of two promoters and the complete genomic sequence for the Wiskott-Aldrich syndrome gene. , 1999, Biochemical and biophysical research communications.

[24]  B. Gebhardt,et al.  The inherent quantitative capacity of the reverse transcription-polymerase chain reaction. , 1999, Analytical biochemistry.

[25]  R. Rogers,et al.  Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions. , 1999, American journal of respiratory cell and molecular biology.

[26]  U. Francke,et al.  Novel mutations in the Wiskott‐Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes , 1999, Human mutation.

[27]  L. Maquat,et al.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. , 1998, Trends in biochemical sciences.

[28]  Yoshimi Takai,et al.  Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP , 1998, Nature.

[29]  S. Kanner,et al.  Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. , 1997, Blood.

[30]  F. Finkelman,et al.  Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. , 1997, Journal of immunology.

[31]  K. Siminovitch,et al.  Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome , 1996, Human Genetics.

[32]  A. Meindl,et al.  Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product , 1996, Human Genetics.

[33]  O. Parolini,et al.  High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. , 1995, Blood.

[34]  R. Blaese,et al.  Scanning of the Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. , 1995, Human molecular genetics.

[35]  R. Blaese,et al.  Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Sullivan,et al.  A multiinstitutional survey of the Wiskott-Aldrich syndrome. , 1994, The Journal of pediatrics.

[37]  U. Francke,et al.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.

[38]  D. Kenney Wiskott‐Aldrich syndrome and related X‐linked thrombocytopenia , 1990 .

[39]  P. Sharp,et al.  Splicing of messenger RNA precursors. , 1987, Science.

[40]  P. Sharp,et al.  Splicing of messenger RNA precursors. , 1985, Harvey lectures.

[41]  J. Mandel,et al.  The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). , 1980, The Journal of pediatrics.

[42]  F. Oski,et al.  Hereditary thrombocytopenia with an intrinsic platelet defect. , 1969, The New England journal of medicine.

[43]  J. Wolff,et al.  Wiskott-Aldrich syndrome: clinical, immunologic, and pathologic observations. , 1967, The Journal of pediatrics.